Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107597817> ?p ?o ?g. }
- W2107597817 abstract "Background Pelvic organ prolapse is common and can be detected in up to 50% of parous women although many are asymptomatic. Oestrogen preparations are used to improve vaginal thinning (atrophy). It is possible that oestrogens, alone or in conjunction with other interventions, might prevent or assist in the management of pelvic organ prolapse, for example by improving the strength of weakened supporting structures. Objectives To determine the effects of oestrogens or drugs with oestrogenic effects alone, or in conjunction with other treatments, both for prevention and treatment of pelvic organ prolapse. Search methods We searched the Cochrane Incontinence Group Specialised Register of trials (searched 6 May 2010), MEDLINE (January 1950 to April 2010) as well as reference lists of relevant articles. Selection criteria Randomised or quasi‐randomised controlled trials that included the use of any oestrogens or drugs with oestrogenic (or anti‐oestrogenic) actions for pelvic organ prolapse. Data collection and analysis Trials were assessed and data extracted independently by two review authors. Main results Three trials and one meta‐analysis of adverse effects of a further three trials were identified. One trial did not provide useable data. Two trials included 148 women with prolapse, one included 58 postmenopausal women and the meta‐analysis reported a mixed population (women with and without prolapse) of postmenopausal women (N=6984). The meta analysis and one other small trial investigated the effect of selective oestrogen receptor modulators (SERMs) for treatment or prevention of osteoporosis but also collected data of the effects on prolapse. Interventions included oestradiol, conjugated equine oestrogen and two (SERMs), raloxifene and tamoxifen. Only one small trial addressed the primary outcome (prolapse symptoms). One small treatment trial of oestradiol for three weeks before prolapse surgery found a reduced incidence of cystitis in the first four weeks after surgery but this unexpected finding needs to be confirmed in a larger trial. A meta‐analysis of adverse effects of a SERM, raloxifene (used for treatment or prevention of osteoporosis in postmenopausal women) found a statistically significant reduction in the need for prolapse surgery at three year follow up (OR 0.50, 95% CI 0.31 to 0.81), but this was statistically significant only in women older than 60 years (OR 0.68, 95% CI 0.22 to 2.08) and the total number of women having prolapse surgery was small. A further small trial comparing conjugated equine oestrogen, raloxifene, tamoxifen and placebo in postmenopausal women having pelvic floor muscle training was too small to detect effects on prolapse outcomes. Authors' conclusions There was limited evidence from randomised controlled trials regarding the use of oestrogens for the prevention and management of pelvic organ prolapse. The use of local oestrogen in conjunction with pelvic floor muscle training before surgery may reduce the incidence of post‐operative cystitis within four weeks after surgery. Oral raloxifene may reduce the need for pelvic organ prolapse surgery in women older than 60 years although this cannot be taken as an indication for practice. There is a need for rigorous randomised controlled trials with long term follow up to assess oestrogen preparations for prevention and management of pelvic organ prolapse, particularly as an adjunctive treatment for women using pessaries and also before and after prolapse surgery." @default.
- W2107597817 created "2016-06-24" @default.
- W2107597817 creator A5012483878 @default.
- W2107597817 creator A5047583469 @default.
- W2107597817 creator A5069653291 @default.
- W2107597817 date "2010-09-08" @default.
- W2107597817 modified "2023-10-12" @default.
- W2107597817 title "Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women" @default.
- W2107597817 cites W1599864597 @default.
- W2107597817 cites W1807388580 @default.
- W2107597817 cites W1967312126 @default.
- W2107597817 cites W1970477430 @default.
- W2107597817 cites W1984902625 @default.
- W2107597817 cites W1995469944 @default.
- W2107597817 cites W1997611155 @default.
- W2107597817 cites W1997883187 @default.
- W2107597817 cites W1998879972 @default.
- W2107597817 cites W2005552781 @default.
- W2107597817 cites W2006291806 @default.
- W2107597817 cites W2006912241 @default.
- W2107597817 cites W2007918173 @default.
- W2107597817 cites W2009785563 @default.
- W2107597817 cites W2011073547 @default.
- W2107597817 cites W2011246022 @default.
- W2107597817 cites W2015635389 @default.
- W2107597817 cites W201704258 @default.
- W2107597817 cites W2017713544 @default.
- W2107597817 cites W2018871379 @default.
- W2107597817 cites W2019668236 @default.
- W2107597817 cites W2025580183 @default.
- W2107597817 cites W2028057926 @default.
- W2107597817 cites W2036848307 @default.
- W2107597817 cites W2042311723 @default.
- W2107597817 cites W2046487365 @default.
- W2107597817 cites W2048946213 @default.
- W2107597817 cites W2054323331 @default.
- W2107597817 cites W2057973830 @default.
- W2107597817 cites W2058703708 @default.
- W2107597817 cites W2062792429 @default.
- W2107597817 cites W2068266555 @default.
- W2107597817 cites W2068655354 @default.
- W2107597817 cites W2072934738 @default.
- W2107597817 cites W2074919272 @default.
- W2107597817 cites W2077589081 @default.
- W2107597817 cites W2080870308 @default.
- W2107597817 cites W2081571455 @default.
- W2107597817 cites W2095345737 @default.
- W2107597817 cites W2109183745 @default.
- W2107597817 cites W2110767908 @default.
- W2107597817 cites W2112233548 @default.
- W2107597817 cites W2112629831 @default.
- W2107597817 cites W2115632135 @default.
- W2107597817 cites W2116575257 @default.
- W2107597817 cites W2125435699 @default.
- W2107597817 cites W2141242014 @default.
- W2107597817 cites W2143205374 @default.
- W2107597817 cites W2145571247 @default.
- W2107597817 cites W2145655238 @default.
- W2107597817 cites W2146953983 @default.
- W2107597817 cites W2149815829 @default.
- W2107597817 cites W2154645837 @default.
- W2107597817 cites W2166281097 @default.
- W2107597817 cites W4240029786 @default.
- W2107597817 cites W4246731109 @default.
- W2107597817 cites W4292806894 @default.
- W2107597817 cites W4297889754 @default.
- W2107597817 doi "https://doi.org/10.1002/14651858.cd007063.pub2" @default.
- W2107597817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20824855" @default.
- W2107597817 hasPublicationYear "2010" @default.
- W2107597817 type Work @default.
- W2107597817 sameAs 2107597817 @default.
- W2107597817 citedByCount "60" @default.
- W2107597817 countsByYear W21075978172012 @default.
- W2107597817 countsByYear W21075978172013 @default.
- W2107597817 countsByYear W21075978172014 @default.
- W2107597817 countsByYear W21075978172015 @default.
- W2107597817 countsByYear W21075978172016 @default.
- W2107597817 countsByYear W21075978172017 @default.
- W2107597817 countsByYear W21075978172018 @default.
- W2107597817 countsByYear W21075978172019 @default.
- W2107597817 countsByYear W21075978172020 @default.
- W2107597817 countsByYear W21075978172021 @default.
- W2107597817 countsByYear W21075978172022 @default.
- W2107597817 countsByYear W21075978172023 @default.
- W2107597817 crossrefType "journal-article" @default.
- W2107597817 hasAuthorship W2107597817A5012483878 @default.
- W2107597817 hasAuthorship W2107597817A5047583469 @default.
- W2107597817 hasAuthorship W2107597817A5069653291 @default.
- W2107597817 hasConcept C126322002 @default.
- W2107597817 hasConcept C126894567 @default.
- W2107597817 hasConcept C131872663 @default.
- W2107597817 hasConcept C142724271 @default.
- W2107597817 hasConcept C168563851 @default.
- W2107597817 hasConcept C197934379 @default.
- W2107597817 hasConcept C204787440 @default.
- W2107597817 hasConcept C27081682 @default.
- W2107597817 hasConcept C2777910003 @default.
- W2107597817 hasConcept C2778531004 @default.
- W2107597817 hasConcept C29456083 @default.
- W2107597817 hasConcept C3018603563 @default.